Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction
July 31, 2023 19:27 ET
|
Assertio Holdings, Inc.
Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market Access and Growth Across All Products Transaction Expected to be...
Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals
July 27, 2023 16:01 ET
|
Assertio Holdings, Inc.
Stockholders From Both Assertio and Spectrum Have Overwhelmingly Voted in Support of the Transaction Transaction Expected to be Significantly Accretive to Assertio in 2024 LAKE FOREST, Ill. and...
Moore Kuehn Encourages SYNH, SPPI, ARNC and EMBK Investors to Contact Law Firm
July 03, 2023 11:37 ET
|
Moore Kuehn
NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
ALERT: The M&A Class Action Firm Continues the Investigation of the Merger – MYBF, RXDX, SPPI, TRTN
April 26, 2023 17:41 ET
|
Monteverde & Associates PC
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction
April 25, 2023 06:00 ET
|
Assertio Holdings, Inc.; Spectrum Pharmaceuticals, Inc.
Complementary Commercial Growth Platforms Anticipated to Accelerate ROLVEDON™ (eflapegrastim-xnst) Injection Profitability and Diversify Revenue Streams Combination of Assertio’s Omni-Channel...
ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action– SPPI
January 10, 2023 19:15 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between...
ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm– SPPI
January 02, 2023 19:30 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 02, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPPI
December 23, 2022 17:28 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 23, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between...
Kaplan Fox Reminds Investors with Losses in Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) of Upcoming Lead Plaintiff Deadline
December 20, 2022 17:51 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) filed a proposed class action suit in the United States District Court for the Southern District of...
DEADLINE ALERT for SPPI and LDI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
November 01, 2021 12:15 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...